Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousTissue DonorsGraft vs Host DiseaseHistocompatibility TestingTransplantation, AutologousWhole-Body IrradiationHistocompatibilityAnemia, AplasticHematopoietic Stem Cell TransplantationTransplantation ConditioningLeukemiaBone and BonesGraft SurvivalHematopoietic Stem CellsLiver TransplantationTransplantation ChimeraBone Marrow PurgingBone Marrow DiseasesBusulfanHLA AntigensGraft vs Host ReactionBone Marrow ExaminationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCyclophosphamideLeukocyte TransfusionTransplantation, IsogeneicHematopoiesisRecurrenceLiving DonorsHematologic NeoplasmsTissue and Organ ProcurementKidney TransplantationGraft RejectionTreatment OutcomeMice, Inbred C57BLTime FactorsBone Marrow NeoplasmsRadiation ChimeraBlood DonorsImmunosuppressionCombined Modality TherapyLeukemia, Myeloid, AcuteAcute DiseaseImmunosuppressive AgentsRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaT-LymphocytesHepatic Veno-Occlusive DiseaseSurvival AnalysisLeukemia, MyeloidColony-Forming Units AssayRetrospective StudiesTransplantation ImmunologyBone RemodelingLymphocyte DepletionStem Cell TransplantationLymphoma, Non-HodgkinHeart TransplantationChimeraMyelodysplastic SyndromesCord Blood Stem Cell TransplantationSevere Combined ImmunodeficiencySurvival RateCell DifferentiationHematologic DiseasesDisease-Free SurvivalLung TransplantationCyclosporineActuarial AnalysisPancytopeniaLymphocyte TransfusionSpleenBone DensityAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyLeukocyte CountFlow CytometryCarmustineOrgan TransplantationGranulocyte Colony-Stimulating FactorCells, CulturedGraft vs Tumor EffectMice, Inbred BALB CFollow-Up StudiesCytarabineCytomegalovirus InfectionsMultiple MyelomaGraft vs Leukemia EffectAntigens, CD34Bone ResorptionMelphalanGranulocytesLymphomaEtoposideMice, KnockoutRegistriesImmunophenotyping